menu
    • menu
    [{"orgOrder":0,"company":"Chiba University","sponsor":"Kissei Pharmaceutical | International University of Health and Welfare","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"JAPAN","productType":"Miscellaneous","year":"2024","type":"Inapplicable","leadProduct":"Avacopan","moa":"C5a anaphylatoxin chemotactic receptor","graph1":"Immunology","graph2":"Phase IV","graph3":"Chiba University","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Chiba University \/ Kissei Pharmaceutical | International University of Health and Welfare","highestDevelopmentStatusID":"11","companyTruncated":"Chiba University \/ Kissei Pharmaceutical | International University of Health and Welfare"}]

    Find Clinical Drug Pipeline Developments & Deals by Chiba University

    Menu

    Chiba University

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Chiba University

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Chiba University

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Avacopan

                            Therapeutic Area : Immunology

                            Study Phase : Phase IV

                            Sponsor : Kissei Pharmaceutical | International University of Health and Welfare

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis

                            Details : Avacopan is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of ANCA-associated with Vasculitis.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            September 25, 2024

                            Lead Product(s) : Avacopan

                            Therapeutic Area : Immunology

                            Highest Development Status : Phase IV

                            Sponsor : Kissei Pharmaceutical | International University of Health and Welfare

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth